Genentech, Inc.- Hoffmann-La Roche - Roche Holding AG
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions.
We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.
We focus our research and development practice on discovering and developing new medicines for unmet medical needs. Right now, the Genentech Research and Early Development pipeline has more than 20 new molecular entities in clinical development.